Skip to content
DeepViews

Constellation Brands, Inc. (STZ) — Analysis Summary

Constellation Brands, Inc. (STZ) has a market cap of $22.32B with year-over-year revenue growth of -10.5%. Net margin stands at 18.5%. The stock trades at a P/E ratio of 12.2.

Key Takeaways

  • Revenue changed -10.5% year-over-year
  • Net margin of 18.5%
  • P/E ratio of 12.2

Compared to other companies in the BEVERAGES sector, STZ posted revenue growth of -10.5% and trades at a P/E of 12.2.

[XNYS]

Constellation Brands, Inc. (STZ)

$130.69

UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$22.32B
Enterprise Value
$31.65B
P/E Ratio
12.2
Div Yield
3.15%
EV/EBITDA
9.7
Company Profile
About
About Constellation Brands, Inc.

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating more than 90% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 10% stake in Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.

Sector

BEVERAGES

Employees

9,400

Headquarters

ROCHESTER, NY

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
41
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$8549.80M
Total Debt$9431.20M
Debt-to-Equity1.10
Cash & Equivalents$96.60M

Cash Flow

Operating Cash Flow$2693.60M
Free Cash Flow$1834.20M
FCF Margin20.25%
P/FCF Ratio12.17
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$4.12

Dividend Yield

3.15%

Quarterly
Last Ex-Date: 2026-07-30

Dividend History

2026-07-30
CD$1.0300
2026-04-29
CD$1.0300
2026-01-29
CD$1.0200
2025-10-30
CD$1.0200
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.